CDSCO

Pavan Choudary, Chairman, MTaI stated, "We feel that domestic and international currents will together help carve out key policy…

The NeuMoDx platform delivers fast turnaround times utilising an intuitive 3-step workflow for informed clinical decisions

The technology aims to provide an affordable and efficient solution to screen large populations as a point of care test for…

The product has already been approved by USFD

CDSCO has granted permission to CMC, Vellore, to conduct phase-IV study with Covishield and Covaxin to compare immunogenicity of…

Hetero is the first biopharma company in India to receive Manufacturing and Marketing (M&M) approval for the product…

CDSCO has received total of 22 applications for manufacturing and marketing of the drug Molnupiravir in the country

The kit has also received formal approval from the Indian Council of Medical Research (ICMR)

The Central Drugs Standard Control Organisation (CDSCO) has issued an order allowing the existing manufacturers/ importers of…

Submits Phase I/II clinical trial data of ZyCoV-D, which reportedly shows immunogenicity in Phase II in healthy subjects as also…